Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder

NCT00216723 · clinicaltrials.gov ↗

COMPLETED

Status

3000

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Bipolar Disorder

Interventions

DRUG: Aripiprazole

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.